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Summary
A study was conducted to evaluate a natural carbohydrate fraction Actigen™ (NCF), derived from mannanoligosaccharide, in
feed on growth performance, intestinal morphology and goblet cell number and area of male broilers’. Dietary treatments
included: 1) control diet (antibiotic and NCF free), 2) NCF at 200 g/t, 3) NCF at 400 g/t, and 4) NCF 800 g/t. Two hundred
and forty birds were placed into 12 replicate pens per treatment (5 birds/pen), sixty birds per treatment. Body weight and feed
intake were recorded weekly up to day 42. At this time a 2.5cm section of jejunum and duodenum were excised post mortem
for morphological analysis. Birds fed 200 g/t and 800 g/t NCF were signiﬁcantly (P < 0.01) heavier from day 14 onwards than
the control birds. Feed intake was signiﬁcantly higher in birds fed 200 g/t NCF compared to those fed the control at 21 and 35
days (P < 0.05). Diets containing 200 g/t and 800 g/t of NCF signiﬁcantly decreased broiler feed conversion ratio (FCR) com-
pared to the control in the ﬁrst phase (1–14 days) (P < 0.01) and levels of NCF decreased FCR (P < 0.05) in the second phase
(15–28 days). NCF had no signiﬁcant effect on villus height, villus width, crypt depth or villus to crypt ratio in either duo-
denum or jejunum. NCF did not signiﬁcantly affect goblet cell area or goblet cell number in the duodenum, however, in
the jejunum, 800 g/t NCF signiﬁcantly (P < 0.05) increased goblet cell area over the control. In conclusion, NCF showed
a positive effect on broiler performance in the starter and grower phases, and increased goblet cell area in the jejunum,
suggesting higher levels of mucin production. This indicated that the performance beneﬁt of NCF could be age-dependent,
with younger birds responding more than the older ones. There were no additional beneﬁts to performance when feeding NCF
for a longer period (after 28 d of age), however it is postulated that birds fed NCF would have greater defence to pathogenic
challenge through increased storage capacity of mucin.
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Introduction
Over the past few years there has been increased concern
about antibiotic resistant bacteria and the inclusion of
antibiotics in animal diets for growth promotion. This
led to the ban of a number of antibiotic growth promo-
ters (Dibner and Richards, 2005). Since the EU ban on
using antibiotics as growth promoters in 2006 (Huff
et al., 2006), there has been an increase in the incidence
of endemic diseases in poultry (Chee, 2008), in addition
to reports of slower growth and higher disease challenges
causing signiﬁcant economic losses (Thomke and
Elwinger, 1998) and negative welfare implications for
poultry. In particular, gut health has been affected, and
without a healthy intestinal tract a broiler cannot reach
its full performance potential. Due to this, there has
been a drive in the market for feed supplements that
will improve health and production of poultry, but remain
safe for humans. The morphological structure of the gas-
trointestinal tract (GIT) offers key information to evaluate
gut health. Longer, thinner villi are considered to indicate
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that the bird will have a better ability to absorb nutrients,
due to increased surface area (Gao et al., 2008). Shorter
villi height (VH) and deeper crypt depth (CD) are associ-
ated with decreased digestibility of nutrients (Zhang et al.,
2005). Deeper CD are considered a negative indication of
gut health because new epithelial cells are produced in the
crypts and migrate along the villi to the tip (Gao et al.,
2008), therefore a deeper CD indicates that there is a
higher tissue turnover of epithelium cells. It is thought
that the faster turnover of tissue is due to the host com-
pensating for villus atrophy, due to inﬂammation resulting
from pathogens and their toxins (Gao et al., 2008).
Mannanoligosaccharides (MOS) are mannose-based car-
bohydrates that can be derived from yeast cell walls and have
a prebiotic function (Chee, 2008). MOS has been shown to
have a positive effect on gut heath, by binding to entero-
pathogens, inhibiting their proliferation and stimulating
speciﬁc microbial populations in the GIT (Spring et al.,
2000; Kocher et al., 2004). This leads to increased VH and
decreased CD, which may in turn improve nutrient absorp-
tion (Santin et al., 2001; Sims, 2004; Mourão et al., 2006).
Goblet cells are found in the epithelial layer along the villi
of the bird’s GIT. Goblet cells produce and secrete mucin
glycoproteins that make up part of the mucus layer, which
protects the intestinal surface against damage by bacterial
and environmental toxins, microorganisms and some
coarse dietary components (Santos et al., 2007). Several
studies have found that feeding MOS increases the number
and/or the volume of goblet cells found in the small intes-
tinal tract (Baurhoo et al., 2009; Brummer et al., 2010). It
has not only been found that MOS increased the number
of goblet cells, but also their size (Uni and Smirnov, 2006).
Mucin is thought to be beneﬁcial to developing the innate
immune system (Koutsos and Arias, 2006).
Actigen™ (Alltech Inc., Nicholasville, Kentucky, USA),
is a speciﬁc natural carbohydrate fraction (NCF) that has
been derived from the cell wall of Saccharomyces cerevisiae.
NCF contains a high afﬁnity for the mannose- speciﬁc
type-1 ﬁmbriae of pathogenic bacteria such as Escherichia
coli (Ofek et al., 1977) and Salmonellae (Spring et al., 2000;
Miguel et al., 2004). The objective of this study was to
evaluate the effect of this speciﬁc natural carbohydrate
fraction isolated from yeast cell wall oligosaccharides, on
VH, CD and the goblet cell proﬁles of broilers.
Materials and methods
Two hundred and forty one-day-old male Ross 308 broi-
lers were placed in 48 pens, each containing ﬁve birds
and fed one of four dietary treatments (12 replicates
for each treatment), which were allocated as a random-
ised block design. The room temperature was initially
adjusted to 32oC and then gradually lowered to reach
approximately 21oC by day 21. Temperature was moni-
tored on a daily basis and light was 23L:1D for the dur-
ation of the experiment. Birds were kept on ﬁne sand
litter, with a calculated stocking density of 30 kg per
m2 on day 42. Birds were provided with ad libitum access
to water and feed. Feed was a wheat/soya based mash
containing no enzymes or coccidiostats. The trial lasted
42 days with a three phase feeding programme, starter
(1 to 14 d); grower (15 to 28 d) and ﬁnisher (29 to 42 d).
The basal diet was formulated and made by Target feeds
(Coton, Whitchurch, Shropshire, UK) and the formu-
lations are shown in Table 1.
The four dietary treatments used were; 1) control (anti-
biotic and NCF free), 2) NCF 200 g/t, 3) NCF 400 g/t,
and 4) NCF 800 g/t. Weekly and overall feed intakes and
weight gainswere recorded andFCRwas calculated and cor-
rected for mortality. At the end of the 42 day trial, a 2.5cm
section of jejunum and duodenum were removed and
immediately rinsed with PBS solution. The tissue was then
placed in Bouin’s ﬁxative for eight hours and then stored
in 70% industrial methylated spirits. The tissue samples
were then embedded in parafﬁn and cut at 8 µm intervals
using a rotary microtome (Leitz Wetzlar 1512 microtome
Leitz, Milton Keynes, Bucks, UK). The sections were
Table 1. Composition of basal diet and calculated analysis of the
basal diet
Item Starter Grower Finisher
Ingredients (%)
Barley 10.60 8.46 7.23
Wheat 50.00 55.00 60.00
Soybean meal, 48% CP 26.00 23.00 19.00
Full-fat soybean meal 5.00 5.00 0.50
L lysine HCL 0.31 0.26 0.25
DL methionine 0.38 0.35 0.33
L threonine 0.14 0.13 0.14
Soya oil 4.00 4.50 4.75
Limestone 1.25 1.25 1.25
Monocalcium phosphate 1.50 1.25 1.25
Salt 0.25 0.25 0.25
Sodium bicarbonate 0.15 0.15 0.15
Premix* 0.40 0.40 0.40
Calculated analysis
ME MJ/kg 12.80 13.00 13.20
CP % 21.80 20.60 19.10
Lys % 1.37 1.16 1.13
Met + Cys % 1.01 0.95 0.89
Ca 0.96 0.90 0.90
Total P 0.73 0.66 0.65
*Premix supplied per kg diet: Mn 100 mg, Zn 80 mg, Fe 20 mg, Cu 10 mg, I 1 mg, Mb
0.48 mg, Se 0.2 mg, retinol 13.5 mg, cholecalciferol, 3 mg, tocopherol 25 mg, mena-
dione 5.0 mg, thiamine 3 mg, riboflavin 10.0 mg, pantothenic acid 15 mg, pyroxidine
3.0 mg, niacin 60 mg, cobalamin 30 µg, folic acid 1.5 mg, biotin 125 mg
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stained with a combination of 1% alcian blue (pH 2.5) and
periodic acid-Schiff’s reagent. The following measurements
were taken using a light microscope; CD, VH, villus width
(VW), villus/crypt ratio (VCR), and goblet cell area and
number in the jejunum. VH was measured as the length
between the villus-crypt axis and the tip of the villus (20
villi per sample, 240 per treatment).
The VW was measured at the midpoint between the
villus-crypt axis and the tip of the villus. CD was measured
from the villus-crypt axis to the base of the speciﬁc crypt.
Goblet cell area was measured as the ‘cup’ area of the gob-
let cells (µm2). Ten measurements on 20 villi were made
for each intestinal sample. Goblet cell density was deter-
mined as the number of goblet cells per 165 µm, with
samples obtained from nine pens per treatment. Gut mor-
phology was analysed using an Olympus BX51 micro-
scope ﬁtted with an Olympus DP71 camera (Olympus
Microscopy, Essex, UK) and Cell F software (Olympus
Europa GmbH, Hamburg) used for all measurements.
Gut morphology measurements and performance data
were analysed using SPSS software version 12 for
Windows, with the data being initially analysed for normal-
ity. If the data was normally distributed a one-way
ANOVA was used, if the data was not normally distribu-
ted a Kruskal-Wallis test was performed. Treatment means
were separated using the Bonferroni’s post hoc test,
and statistical signiﬁcance was declared at P < 0.05.
Institutional and national guidelines for the care and use
of animals were followed, and all experimental procedures
involving animals were approved by the Nottingham Trent
University College of Science Ethical Review Committee.
Results and discussion
Live body weight and FCR results are presented in Table 2.
Body weight and FCR means were derived from 12
pens per treatment, except for between 15–28 days for
the 200 g/t and 800 g/t treatments, where 11 pens per
treatment were used due to mortality. FCR means at
29–42 days for NCF 200 g/t were derived from 11
pens per treatment due to data loss from accidental
feed spillage in one pen.
Signiﬁcant (P < 0.01) differences between treatments
were observed for body weight on days 14, 21, 28, 35
and 42. Over the whole trial period, the feeds containing
either 200 g/t or 800 g/t NCF increased live weight com-
pared to the control. Feed intakewas signiﬁcantly increased
for birds fed 200 g/t of NCF over the control at days 21
and 35 (respectively P = 0.021, P = 0.025, data not
shown). For FCR, signiﬁcant differences were observed
in the ﬁrst (1–14 d) and second phase (15–28 d) of feeding.
Diets containing 200 g/t and 800 g/t NCF resulted in sig-
niﬁcantly lower FCR compared to the control in the ﬁrst
phase (P < 0.01), whereas in the second phase all inclusion
levels of NCF decreased FCR (P < 0.05). However the
FCR seen in week one for the control and 400 g/t NCF
was abnormally high for nutritionally complete diets, indi-
cating excessive spillage. Mortality for the treatment
groups was not signiﬁcantly different from the control.
Morphometric measurements from the stained slides
are shown in Table 3. It was observed that NCF had
no signiﬁcant effect on VH, VW, CD or VCR in either
the jejunum or duodenum.
When examining the goblet cell numbers and area in
the duodenum (Table 4), it was concluded that the
diets including NCF did not signiﬁcantly affect goblet
cell area, goblet cell number per 165 µm or goblet cell
measurements as a ratio, however, in the jejunum,
birds fed 800 g/t NCF showed signiﬁcantly (P < 0.05)
increased goblet cell area compared to the control.
Table 2. Effect of NCF in broiler diets on the average body weight (g/bird) and FCR
Dietary NCF treatment
Parameter Age d Control 200 g/t 400 g/t 800 g/t SEM
Body wt 1 43 44 44 43 0.34
(g) 7 102 114 107 107 2.02
14 217a 303c 250ab 291bc 8.15
21 525a 715b 600ab 680b 20.42
28 1026a 1335b 1198ab 1287b 31.60
35 1765a 2119b 1943ab 2112b 39.76
42 2516a 2867b 2655ab 2842b 42.16
FCR 0–14 2.03a 1.59b 1.91ab 1.61b 0.05
15–28 1.85a 1.61b 1.63b 1.63b 0.03
29–42 1.76 1.81 1.84 1.82 0.02
0–42 1.80 1.73 1.76 1.74 0.01
a–cDiffering superscripts in a row denote means are significantly different at P < 0.05
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Duodenum and jejunum goblet cell means are from
nine pens per treatment.
Duodenum gut morphology samples were taken from
birds selected from 12 pens per treatment, and jejunum
gut morphology samples from 12 pens for NCF 200
g/t and 11 pens for the control, 400 g/t and 800 g/t
due to the loss of one sample per treatment from histo-
logical processing.
Supplementation of diets with 200 g/t and 800 g/t
NCF signiﬁcantly increased broiler weekly body weights
compared to the control diet from 14 days, but the
inclusion level of 400 g/t NCF did not signiﬁcantly
change body weight from the control. This indicated
that there may be different mechanisms behind the
observed response to supplementation; one occurring
at the lowest inclusion and one occurring at the highest
inclusion, with apparently antagonist effects at the
median level. This contradicts both Reisinger et al.
(2012) and Gao et al. (2008), who found a positive quad-
ratic response in broiler body weight to both a yeast
derivative and yeast cell culture. From these responses,
it was considered that the higher inclusion levels were
interacting with the immune system, causing energy to
be partitioned towards the immune system, rather than
supporting growth. Whilst this mechanism may explain
the observed response at 400 g/t NCF in the current
trial, it does not support the improved performance at
800 g/t NCF.
Increased body weight following supplementation with
other yeast cell wall material MOS (such as that observed
at 200 g/t and 800 g/t in the current study) has been
attributed to the reduced effects of pathogenic bacteria
in the intestinal tract as the binding of pathogenic bacteria
to MOS results in their evacuation from the intestine
with other non-digested feedstuffs (Spring et al., 2000).
This may have reduced sloughing of villi in birds fed
MOS, thereby contributing to increased performance
compared to the control, due to an increased capacity
to absorb nutrients (Sun et al., 2005). When feeding
NCF to broilers it could be postulated that birds will
also have longer VH and shorter CD via a similar
reduction in sloughing. This is because Spring et al.
(2000) reported that pathogens with the mannose-
speciﬁc type-1 ﬁmbriae, such as some strains of
Escherichia coli, Salmonella typhimurium and Salmonella enteri-
tidis, are attracted to mannans, which are reported to be
present in NCF (Che et al., 2012), and preferentially
bound to them instead of attaching to intestinal epithelial
cells (Castillo et al., 2008). Therefore these pathogenic
bacteria cannot colonise the GIT and release toxins.
These bacterium and their toxins can cause inﬂammation
that in turn cause atrophy of the epithelial cells of the villi
Table 3. Effect of NCF on the gut morphology of the duodenum and jejunum (µm)
Parameter Control NCF 200 g/t NCF 400 g/t NCF 800 g/t SEM
Duodenum
Villus Height (µm) 2819 2791 2896 2704 53.3
Villus Width (µm) 274 265 262 282 5.5
Crypt Depth (µm) 202 202 210 213 5.9
Villus/Crypt Ratio 15.1 13.6 14.2 13.2 0.47
Jejunum
Villus Height (µm) 1284 1285 1379 1315 25.5
Villus Width (µm) 247 235 234 249 5.9
Crypt Depth (µm) 159 151 155 158 2.7
Villus/Crypt Ratio 8.1 8.6 8.9 8.4 0.17
Differences were not statistically significant (P > 0.05)
Table 4. Effect of NCF on the goblet cell (GC) of the duodenum and jejunum
Parameter Control NCF 200 g/t NCF 400 g/t NCF 800 g/t SEM
Duodenum
GC Area (µm2) 59.2 69.4 58.3 62.6 2.5
No of GC per 165µm 11.8 11.4 11.7 11.9 0.2
GC Area per 165µm 683.1 747.0 664.4 719.3 23.6
Jejunum
GC Area (µm2) 67.6b 68.3b 73.8ab 82.8a 2.2
No of GC per 165µm 12.4 12.2 12.0 11.8 0.2
GC Area per 165µm 847.0 868.0 882.1 988.4 21.9
a–cDiffering superscripts in a row means are significantly different at P < 0.05
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(Gao et al., 2008), thus reducing the absorptive function
of the gut through shorter VH and deeper CD (Yason
et al., 1987). If the NCF bind the pathogenic bacteria
and reduce their levels in the GIT, there will be less
villi damage in the gut, therefore improving the gut health
of the bird. To compensate for this atrophy, the bird has
to increase its tissue turn over, and as epithelial cells are
produced in the crypts and migrate along the villi to the
tip, it is thought that the higher turnover in the crypt cell
cause it to become deeper (Gao et al., 2008). Therefore
shallower CD can be considered a good indicator of
gut health. MOS are also thought to increase the number
of beneﬁcial bacteria in the gut.
Morphometric analysis at six weeks of age revealed that
NCF had no signiﬁcant effect on the gut morphology of
the birds at this time point. A possible reason for this
may be due to the birds not being challenged with patho-
genic microbes at this point. This trial supports the VH
ﬁndings of White, et al. (2002) in pigs and Yitbarek
et al. (2012) and Sohail et al. (2012) in broilers when feed-
ing MOS. However, Iji et al. (2001) and Zhang et al.
(2005) found that birds fed yeast cell wall fractions had
longer VH than control birds at 21 days. Similarly,
Baurhoo et al. (2007) measured VH and found that
MOS improved VH at 28 days but not at 42 days. A
similar, early age response may have occurred in this pre-
sent study, but as histological measures were not taken at
21 or 28 days this cannot be veriﬁed.
When looking at CD, Zhang et al. (2005), Yitbarek et al.
(2012) and Sohail et al. (2012) found feeding MOS had
no effect on CD in birds, as seen in this study. Santin
et al. (2001) also saw no effect of MOS at 42 days, how-
ever decreased CD was observed at seven days of age in
broilers fed MOS. In addition, the present study found
no effect on VCR, which can be used as a marker of
overall intestinal health, as it takes into account both
CD and VH. This trial included a total of 240 measures
for each treatment, which is a considerable amount, and
it should be noted that taking more measures to try and
reduce associated error would have major time and cost
implications. The inherent variability both in this study
and other studies suggests that measuring VH and CD
may not be an optimal approach to quantifying gut
health.
This study showed that the greatest beneﬁt of feeding
NCF on FCR occurred at the beginning of the trial, indi-
cating there may be an optimum time for the supplemen-
tation of NCF to increase feeding efﬁciency of the birds.
This may be due to the fact that the gut microﬂora of
younger birds is more transient in nature and less estab-
lished than in older birds, and hence more susceptible
to colonisation by pathogenic bacteria. Therefore prebio-
tic intervention may shorten the time required to create a
beneﬁcial microﬂora population if it is offered early in life.
However, similar studies have found variable early per-
formance effects (Iji et al., 2001; Sun et al., 2005; Zhang
et al., 2005; Midilli et al., 2008). In this study it was gener-
ally shown that NCF improved FCR over the starter and
grower feeding phases. This concurs with the ﬁndings of
Zhang et al. (2005), however it must be mentioned that
other studies have shown no early response (Iji et al.,
2001; Sun et al., 2005; Midilli et al., 2008).
It could be hypothesised that the improvements in
FCR in younger birds fed NCF may have been due to
improved absorption, due to an increase in lactobacilli
and biﬁdobacterial populations and a reduction in patho-
genic bacteria. This has been seen in other studies where
improvements in gut morphology were associated with
increased lactobacilli and biﬁdobacterial populations
(Baurhoo et al., 2009). However, improvements in gut
health were not observed in this present study, as histo-
logical measurements were only recorded at 42 d of age,
when the microﬂora was probably already established
with a stable population of beneﬁcial bacteria. This
means that birds on treatment diets were not under
any challenge, which would explain why NCF had no
effect on the performance in the last phase of the trial,
which is consistent with the histological measurements
at 42 d.
There is no consensus on whether an increase in goblet
cell numbers and area is considered an improvement in
bird health. Increasing the number and area of goblet
cells is thought to improve the volume of mucin stored
in the GIT and, possibly, its production (Brümmer
et al., 2010). Mucin is essential for a number of brush
border processes, including facilitating absorption of
nutrients, enzyme production, lubrication and decreasing
the binding and colonisation ability of pathogenic bac-
teria to the intestine (Blomberg et al., 1993; Smirnov
et al., 2004). An increase in the level of mucin could
have a beneﬁcial effect on the ﬁrst line of defence of
the immune system (Baurhoo et al., 2009) and the
absorptive function of the gut. Contrarily, overproduc-
tion of mucin may result in an negative effect, by increas-
ing the mucus thickness on the GIT wall to a level that
might negatively affect the absorption of nutrients
through the gut epithelium (Smirnov et al., 2004;
Brummer et al., 2010).
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In this study, the number and area of goblet cells in the
duodenum and jejunum were not affected by supplemen-
tation with any levels of NCF at 42 days. This would
suggest that NCF has no effect on the mucin proﬁle of
broilers in the duodenum. This absence of response
was also reported by Castillo et al. (2008) and Yitbarek
et al. (2012). Conversely, Baurhoo et al. (2007; 2009),
Chee et al. (2010), Morales-lopez et al. (2010) and
Muthusamy et al. (2012) reported that goblet cell num-
bers were increased by yeast cell wall product supplemen-
tation. In the jejunum NCF increased the area of goblet
cells and there was a trend for larger goblet cell area per
165 µm of villi, which suggested that NCF at 800 g/t
affected the mucin proﬁle of broilers. Published data
on goblet cell area is limited. Brummer et al. (2010)
found that area of goblet cells increased with MOS sup-
plementation. Insight into the mechanisms behind this
goblet cell response would be beneﬁcial to understanding
the effect of NFC supplementation on gut health.
An increase in goblet cell area is thought to show that
its mucin storage capacity has increased (Smirnov et al.,
2005). The increase in mucin storage suggests that the
bird is more capable of forming a protective layer on
the villi, thereby helping protect the intestine from
damage caused by enteropathogens in the event of a chal-
lenge from pathogenic bacteria (Smirnov et al., 2006;
Brümmer et al., 2010). One suggested mechanism of
MOS on mucin production is through changing the
gene expression of key genes through direct crosstalk
between beneﬁcial intestinal microbes and goblet cells
(Mack et al., 1999; Freitas et al., 2003; Smirnov et al.,
2005; Uni and Smirnov 2006; Chee, 2008). The effects
of NCF on the goblet cell area observed in this trial
agree with this suggestion in that goblet cell area was
increased with higher supplementation levels, but it is
also possible that NCF has a direct effect on mucin pro-
duction and subsequently increasing biﬁdobacteria due to
the increase in mucin production, as these microbes can
produce enzymes allowing them to utilise and proliferate
on mucin glycoproteins (Katayama et al., 2005; Jung et al.,
2008; Ruas-Madiedo et al., 2008).
Conclusions
Published research in this ﬁeld appears to be highly vari-
able, which may be due to differences in the type of MOS
product, experimental conditions, diet formulation, or
health status of the birds. This means that the mechan-
ism of action of yeast cell wall carbohydrates, like MOS
and NCF, and interactions with other nutritional and
production parameters are still not fully understood.
Under the conditions of this trial, NCF had a positive
effect on performance in the starter and grower phases,
indicating that the performance beneﬁt of NCF could
be age-dependent, with younger birds responding more
than the older ones. Although there were no additional
performance beneﬁts to feeding NCF for a longer
period, goblet cell area in the jejunum was increased,
suggesting that birds fed NCF would have better
defences to pathogenic challenges due to higher levels
of mucin.
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